-1.png)
Onkológia S1/2020
Treatment of enzalutamide in the therapy of metastatic castration-resistant prostate cancer in postchemoindication
Purpose: The main objective of this case report is to highlight the options of enzalutamid in treatement metastatic castrationresistant prostate cancer in postchemoindications. Case: We present case of patient indicated to treatement of enzalutamid after previous treatemet of hormonal therapy, chemoterapy, radiotherapy. Conclusion: This case shows longterm efect of treatment enzalutamid in postchemoindication.
Keywords: metastatic castration-resistant prostate cancer, postchemoindication, enzalutamide
